View my up-to-date publication list on google scholar or PubMed. Below, you can see my publications as of July 2023 with undergraduate students underlined and my name in bold.
Robbins, L., Balaram, A., Dejneka, S., McMahon, M., Najibi, Z., Pawlowicz, P., and Conrad, W.H. (2023). Heterologous production of the D-cycloserine intermediate O-acetyl-L-serine in a human type II pulmonary cell model. Sci Rep 13, 8551. 10.1038/s41598-023-35632-4.
Osman, M.M., Shanahan, J.K., Chu, F., Takaki, K.K., Pinckert, M.L., Pagán, A.J., Brosch, R., Conrad, W.H., and Ramakrishnan, L. (2022). The C terminus of the mycobacterium ESX-1 secretion system substrate ESAT-6 is required for phagosomal membrane damage and virulence. Proc. Natl. Acad. Sci. U.S.A. 119, e2122161119. 10.1073/pnas.2122161119.
Bousquet, A., Conrad, W.H., Sadat, S.O., Vardanyan, N., and Hong, Y. (2022). Deep learning forecasting using time-varying parameters of the SIRD model for Covid-19. Sci Rep 12, 3030. 10.1038/s41598-022-06992-0.
Chirakos, A.E., Balaram, A., Conrad, W., and Champion, P.A. Modeling Tubercular ESX-1 Secretion Using Mycobacterium marinum. Microbiol Mol Biol Rev 84, e00082-19. 10.1128/MMBR.00082-19.
Osman, M.M., Pinckert, M.L., Peak-Chew, S., Troll, M.A., Conrad, W.H., and Ramakrishnan, L. (2019). Ebselen attenuates mycobacterial virulence through inhibition of ESX-1 secretion. bioRxiv, 828574.
Conrad, W.H., Osman, M.M., Shanahan, J.K., Chu, F., Takaki, K.K., Cameron, J., Hopkinson-Woolley, D., Brosch, R., and Ramakrishnan, L. (2017). Mycobacterial ESX-1 secretion system mediates host cell lysis through bacterium contact-dependent gross membrane disruptions. PNAS 114, 1371–1376. 10.1073/pnas.1620133114.
Conrad, W., Major, M.B., Cleary, M.A., Ferrer, M., Roberts, B., Marine, S., Chung, N., Arthur, W.T., Moon, R.T., Berndt, J.D., et al. (2013). FAM129B is a novel regulator of Wnt/β-catenin signal transduction in melanoma cells. F1000Res 2, 134. 10.12688/f1000research.2-134.v2.
Conrad, W.H., Swift, R.D., Biechele, T.L., Kulikauskas, R.M., Moon, R.T., and Chien, A.J. (2012). Regulating the response to targeted MEK inhibition in melanoma. Cell Cycle 11, 3724–3730. 10.4161/cc.21645.
Conrad, W.H. (2012). Resolving mechanisms of apoptosis in response to WNT3A in Melanoma (University of Washington).
Louie, S.H., Yang, X.Y., Conrad, W.H., Muster, J., Angers, S., Moon, R.T., and Cheyette, B.N.R. (2009). Modulation of the β-Catenin Signaling Pathway by the Dishevelled-Associated Protein Hipk1. PLOS ONE 4, e4310. 10.1371/journal.pone.0004310.
Kategaya, L.S., Changkakoty, B., Biechele, T., Conrad, W.H., Kaykas, A., DasGupta, R., and Moon, R.T. (2009). Bili Inhibits Wnt/β-Catenin Signaling by Regulating the Recruitment of Axin to LRP6. PLOS ONE 4, e6129. 10.1371/journal.pone.0006129.
James, R.G., Biechele, T.L., Conrad, W.H., Camp, N.D., Fass, D.M., Major, M.B., Sommer, K., Yi, X., Roberts, B.S., Cleary, M.A., et al. (2009). Bruton’s Tyrosine Kinase Revealed as a Negative Regulator of Wnt–β-Catenin Signaling. Science Signaling 2, ra25–ra25. 10.1126/scisignal.2000230.
Chien, A.J., Conrad, W.H., and Moon, R.T. (2009). A Wnt Survival Guide: From Flies to Human Disease. Journal of Investigative Dermatology 129, 1614–1627. 10.1038/jid.2008.445.
James, R.G., Conrad, W.H., and Moon, R.T. (2008). β-catenin-independent Wnt pathways: signals, core proteins, and effectors. Wnt signaling: Pathway methods and mammalian models, 131–144.